Laurus Labs
Logotype for Laurus Labs Ltd

Laurus Labs (LAURUSLABS) investor relations material

Laurus Labs Q3 25/26 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Laurus Labs Ltd
Q3 25/26 earnings summary23 Jan, 2026

Executive summary

  • Achieved strong operational and financial performance in Q3 and 9M FY2026, with consolidated revenue for Q3 at ₹1,778.29 crore and 9M revenue at ₹5,044.48 crore, driven by growth in generics, CDMO, and ARV segments.

  • EBITDA for 9M FY26 reached ₹1,303 crore with a margin of 26.1%, up 9.4 percentage points year-over-year.

  • Net profit after tax for Q3 was ₹251.88 crore, and for 9M FY26 was ₹610 crore, up 388% year-over-year.

  • Significant investments made in peptide and ADC infrastructure, with new labs operationalized and GMP facility construction on track.

  • Outlook for FY26 remains positive with healthy operational growth and continued CAPEX investment.

Financial highlights

  • Q3 FY26 revenue: ₹1,778 crore, up 26% year-over-year; 9M FY26 revenue: ₹5,001 crore, up 30% year-over-year.

  • Q3 EBITDA: ₹485 crore (27% margin); 9M EBITDA: ₹1,303 crore (26.1% margin); net profit for 9M: ₹610 crore, up 388% year-over-year.

  • Gross margin for Q3: 60.9%; 9M: 60.1%, up 4.3 percentage points year-over-year.

  • Operating cash flow increased 617% to ₹1,477 crore; CAPEX at ₹735 crore for 9M FY26.

  • ROCE improved to 18.5%; net debt-to-EBITDA reduced to 1.2x.

Outlook and guidance

  • Confident in delivering healthy operational growth for FY2026 and maintaining gross margins around 60% for the coming quarters and next financial year.

  • CapEx for FY2026 expected to be about ₹1,000 crore, with similar levels anticipated for next year.

  • Majority of CDMO FY2027 revenues expected from commercial supplies; healthy growth anticipated over FY2026.

  • Underlying EBITDA margins anticipated to remain high due to better asset utilization and product mix.

  • The company is evaluating the impact of new Indian labour codes effective November 2025.

Laurus Bio, KRKA investment impact
Laurus Synthesis demerger: expected benefits
Q3 consolidated vs standalone profit drivers
CDMO FY27 growth drivers
Rationale for avoiding mAb/sterile manufacturing
500-acre greenfield project timeline
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Laurus Labs earnings date

Logotype for Laurus Labs Ltd
Q4 25/2624 Apr, 2026
Laurus Labs
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Laurus Labs earnings date

Logotype for Laurus Labs Ltd
Q4 25/2624 Apr, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Laurus Labs Limited, a pharmaceutical company, develops, manufactures, and sells active pharmaceutical ingredients (APIs) and formulations in India. It involves in the development of antiviral APIs; generic APIs for hepatitis C and HIV Darunavir tablets; and oncology BCS class II drugs. The company also develops and commercializes single super specialty products comprising linezolid and formoterol. The company was incorporated in 2005 and is based in Hyderabad, India.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage